Industry benchmark SPDR S&P Biotech ETF (XBI ... “After 3 years of painful underperformance, winter is finally thawing and spring just might be in the air,” Kasimov and the team wrote ...

U.S. policies that fix the IRA, strengthen patents, and incentivize antimicrobial research could help hasten new medicines ...

"After biotech's record financial harvest over the last two years, the inevitable IPO winter has arrived, and there are numerous signs that public capital is becoming more scarce – hopefully on ...

Scientists who want a say in the future of their inventions are once again moving from academia to the C-suite ...

That's according to Dr Bianca Ogden, the jewel in Platinum Asset Management's biotech crown, who believes that we are now ...

Laura Varley is a Careers reporter at Silicon Republic. She has a background in technology PR and journalism and is borderline obsessed with film and television, the theatre, Marvel and Mayo GAA ...

With 9 marketed products and 20 clinical programs, Fortress Bio’s business model decreases risk and increases value-creating events for shareholders.